西格玛 Sigma-Aldrich
浏览为
排序由
显示 每页
TWS119,[GSK-3β Inhibitor XII];≥98% (HPLC)
SML1271
别名:3-[6-(3-氨基苯基)-7H-吡咯并[2,3-d]嘧啶-4-基氧基]苯酚;3-[6-(3-Aminophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy]phenol
Empirical Formula (Hill Notation): C18H14N4O2 CAS号: 601514-19-6 分子量: 318.33 MDL编号: MFCD09037535 PubChem化学物质编号: 329825758 NACRES: NA.77
Empirical Formula (Hill Notation): C18H14N4O2 CAS号: 601514-19-6 分子量: 318.33 MDL编号: MFCD09037535 PubChem化学物质编号: 329825758 NACRES: NA.77
TDZD-8,≥98% (HPLC), needles
T8325
别名:GSK-3β Inhibitor I;4-苄基-2-甲基-1,2,4-噻二唑烷-3,5-二酮;4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione
Empirical Formula (Hill Notation): C10H10N2O2S CAS号: 327036-89-5 分子量: 222.26 MDL编号: MFCD04973552 PubChem化学物质编号: 329826879 NACRES: NA.77
Empirical Formula (Hill Notation): C10H10N2O2S CAS号: 327036-89-5 分子量: 222.26 MDL编号: MFCD04973552 PubChem化学物质编号: 329826879 NACRES: NA.77
GDC-0941,[PI 3-K Inhibitor XXI];≥99% (HPLC)
5.09226
别名;GDC0941;Pictrelisib;2-(1H-吲唑-4-基)-6-(4-甲磺酰哌嗪-1-基甲基)-4-吗啉-4-基-噻吩并[3,2-d]嘧啶;2-(1H-Indazol-4-yl)-6-(4-methylsulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2- d]pyrimidine;4-(2-(1H-Indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-4-yl)morpholine;2-(1H-吲唑-4-基)-6-(4-甲烷磺酰基哌嗪-1-基甲基)-4-吗啉-4-基-噻吩并[3,2-d]嘧
Empirical Formula (Hill Notation): C23H27N7O3S2 CAS号: 957054-30-7 分子量: 513.64
Empirical Formula (Hill Notation): C23H27N7O3S2 CAS号: 957054-30-7 分子量: 513.64
KRN633,≥98% (HPLC)
SML0957
别名:KRN-633;N-[2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl]-N′-propyl-urea;N-[2-氯-4-[(6,7-二甲氧基-4-喹唑啉基)氧基]苯基]-N'-丙基脲
Empirical Formula (Hill Notation): C20H21ClN4O4 CAS号: 286370-15-8 分子量: 416.86 NACRES: NA.77
Empirical Formula (Hill Notation): C20H21ClN4O4 CAS号: 286370-15-8 分子量: 416.86 NACRES: NA.77
Ki8751,[VEGFR2 Kinase Inhibitor VI];≥97% (HPLC)
676484
别名:N-(2,4-Difluorophenyl)-Nʹ-(4-(6,7-dimethoxy-4-quinolyloxy)-2-fluorophenyl)urea, Vascular Endothelial Growth Factor Receptor 2 Kinase Inhibitor VI, VEGFR Tyrosine Kinase Inhibitor XXIV, VEGFR2 Kinase Inhibitor VI, 1-(2,4-二氟苯基)-3-(4-((6,7-二甲氧基喹啉-4-基)氧基)-2-氟苯基)脲
Empirical Formula (Hill Notation): C24H18F3N3O4 CAS号: 228559-41-9 分子量: 469.41
Empirical Formula (Hill Notation): C24H18F3N3O4 CAS号: 228559-41-9 分子量: 469.41
A 83-01,[TGF-β RI Kinase Inhibitor IV];≥98% (HPLC)
SML0788
别名:TGF-β RI 激酶抑制剂 IV;ALK4、5和7激酶抑制剂;A-83-01;A83-01;3-(6-甲基-2-吡啶基)-N-苯基-4-(4-喹啉基)-1H-吡唑-1-硫代甲酰胺;3-(6-Methyl-2-pyridinyl)-N-phenyl-4-(4-quinolinyl)-1H-pyrazole-1-carbothioamide
Empirical Formula (Hill Notation): C25H19N5S CAS号: 909910-43-6 分子量: 421.52 NACRES: NA.77
Empirical Formula (Hill Notation): C25H19N5S CAS号: 909910-43-6 分子量: 421.52 NACRES: NA.77
罗拉替尼,Lorlatinib;≥98% (HPLC)
PZ0039
别名:PF-06463922;PF-6463922;(10R)-7-氨基-12-氟-2,10,16-三甲基-15-氧代-10,15,16,17-四氢-2H.8,4-(甲基)吡唑并[4,3.h ] [2,5,11]-苯并二氮杂二环十四癸-3-甲腈;(10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H.8,4-(metheno)pyrazolo[4,3.h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile
Empirical Formula (Hill Notation): C21H19FN6O2 CAS号: 1924207-18-0 分子量: 406.41 MDL编号: MFCD28144520
Empirical Formula (Hill Notation): C21H19FN6O2 CAS号: 1924207-18-0 分子量: 406.41 MDL编号: MFCD28144520
罗拉替尼醋酸盐,Lorlatinib acetate [PF-06463922 acetate];≥98% (HPLC)
PZ0271
别名:醋酸洛拉替尼;罗拉替尼乙酸盐;PF-06463922;PF-6463922;(10R).7-氨基-12-氟-2,10,16-三甲基-15-氧代-10,15,16,17-四氢-2H.8,4-(甲基)吡唑并[4,3.h ] [2,5,11]-苯并二氮杂二环十四癸-3-乙酸乙腈;(10R).7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H.8,4-(metheno)pyrazolo[4,3.h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile acetate, Lorlatinib acetate
Empirical Formula (Hill Notation): C21H19FN6O2 · CH3COOH CAS号: 1924207-18-0 分子量: 466.46 PubChem化学物质编号: 329823805 NACRES: NA.77
Empirical Formula (Hill Notation): C21H19FN6O2 · CH3COOH CAS号: 1924207-18-0 分子量: 466.46 PubChem化学物质编号: 329823805 NACRES: NA.77
GNF-2,≥98% (HPLC), solid
G9420
别名:3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺;Bcr-abl Inhibitor;3-[6-[[4-(Trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]benzamide
Empirical Formula (Hill Notation): C18H13F3N4O2 CAS号: 778270-11-4 分子量: 374.32 MDL编号: MFCD09265253 PubChem化学物质编号: 24724498 NACRES: NA.77
Empirical Formula (Hill Notation): C18H13F3N4O2 CAS号: 778270-11-4 分子量: 374.32 MDL编号: MFCD09265253 PubChem化学物质编号: 24724498 NACRES: NA.77
诺考达唑,Nocodazole;≥99% (TLC), powder
M1404
别名:R 17934;甲基-(5-噻吩甲酰-2-苯并咪唑基)氨基甲酸;甲基N(5-噻吩甲酰-2-苯并咪唑基)氨基甲酸;Methyl N-(5-thenoyl-2-benzimidazolyl)carbamate, Methyl [5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl]carbamate, Oncodazole, R 17934, [5-(2-Thienylcarbonyl)-1H-benzimidazol-2-yl]-carbamic acid methyl ester
Empirical Formula (Hill Notation): C14H11N3O3S CAS号: 31430-18-9 分子量: 301.32 Beilstein: 1085978 EC 号: 250-626-5 MDL编号: MFCD00005588 PubChem化学物质编号: 24278535 NACRES: NA.77
Empirical Formula (Hill Notation): C14H11N3O3S CAS号: 31430-18-9 分子量: 301.32 Beilstein: 1085978 EC 号: 250-626-5 MDL编号: MFCD00005588 PubChem化学物质编号: 24278535 NACRES: NA.77
诺考达唑,Nocodazole;Inhibitor of mitosis, ≥99% (HPLC)
487928
别名:R 17934;甲基-(5-噻吩甲酰-2-苯并咪唑基)氨基甲酸;甲基N(5-噻吩甲酰-2-苯并咪唑基)氨基甲酸;Methyl N-(5-thenoyl-2-benzimidazolyl)carbamate, Methyl [5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl]carbamate, Oncodazole, R 17934, [5-(2-Thienylcarbonyl)-1H-benzimidazol-2-yl]-carbamic acid methyl ester
Empirical Formula (Hill Notation): C14H11N3O3S CAS号: 31430-18-9 分子量: 301.32 MDL编号: MFCD00005588 NACRES: NA.77
Empirical Formula (Hill Notation): C14H11N3O3S CAS号: 31430-18-9 分子量: 301.32 MDL编号: MFCD00005588 NACRES: NA.77
GW2580,≥98% (HPLC)
SML1047
别名: GW 2580;GW-2580;5-[[3-甲氧基-4-[(4-甲氧基苯基)甲氧基]苯基]甲基]-2,4-甲苯酚二胺;5-[[3-甲氧基-4-[(4-甲氧基苯基)甲氧基]苯基]甲基]熔融吡啶-2,4-二胺;5-[[3-Methoxy-4-[(4-methoxyphenyl)methoxy]phenyl]methyl]-2,4-Pyrimidinediamine, 5-[[3-Methoxy-4-[(4-methoxyphenyl)methoxy]phenyl]methyl]pyrimidine-2,4-diamine
Empirical Formula (Hill Notation): C20H22N4O3 CAS号: 870483-87-7 分子量: 366.41 NACRES: NA.77
Empirical Formula (Hill Notation): C20H22N4O3 CAS号: 870483-87-7 分子量: 366.41 NACRES: NA.77
